102 On the other hand, various groups are advocating for that incorporation of novel markers, like a intricate karyotype55 or epigenetic subsets, 27,28 into scientific follow. Every one of these novel prognostic and/or predictive products will must be validated in cohorts of sufferers addressed with specific brokers.Some degree of immunophenotype o